Alternative Pain Therapy For Breast, Prostate And Lung Cancer
6/29/2011
Bio-Nucleonics' lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron®, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer...
Potential To Reduce Side Effects In Anti-Cancer Antibiotics
6/29/2011
Most of us have had a doctor prescribe an antibiotic for a stubborn bacterial infection, or for a cut that gets infected. However, prescribing an antibiotic to fight cancer? In fact, anti-cancer antibiotics have been used since the 1950s to successfully treat several forms of cancer, but often the side effects limit the duration they can be given to a patient...
Ten Minute Talk Boosts Breast Cancer Awareness
6/29/2011
Educating women about breast cancer increases their knowledge about the disease should they develop a symptom - and could help increase survival from breast cancer, new research today shows...
Back-To-Basics Intensive Effort Reduces Bloodstream Infections In Critically Ill Patients
6/29/2011
Nurses on a surgical intensive care unit (SICU) at a large academic medical center cut bloodstream infections to zero and saved more than $200,000 during a six-month period...
Erlotinib Not Recommended For Maintenance Treatment Of Non-Small-Cell Lung Cancer
6/29/2011
NICE has been unable to recommend the use of erlotinib (Tarceva, Roche Products) as a maintenance treatment for people with non-small-cell lung cancer who have had first line treatment with platinum-based chemotherapy and their disease has remained stable. The aim of maintenance treatment is to prolong the benefits of initial treatment and to maximise quality of life for as long as possible...
Research Spend On Cancer Doubles Within A Decade And The Most Fatal Cancers See Investment, UK
6/29/2011
Partners of the National Cancer Research Institute (NCRI) spent more than £500m on cancer research last year, nearly double the amount spent almost ten years ago, according to new figures1. And the amount invested in the three cancers with the poorest survival2 has increased even more over the past decade...
Blocking Key Cell Component Could Make 'Smart Drugs' Effective For Many Cancer Patients, UK
6/29/2011
Cancer Research UK scientists at Newcastle University and researchers based at Harvard University have found that blocking a key component of the DNA repair process could extend the use of a new range of 'smart' cancer drugs called PARP inhibitors. The research is published in Nature Medicine today (Sunday)...
The Benefits Of Breast Screening Shown By Long-Term Study
6/29/2011
Results from the longest running breast screening trial show that screening with mammography reduces the number of deaths from breast cancer. The study*, by researchers at Queen Mary, University of London, shows that the number of deaths that are prevented goes up year after year. The results are new evidence of the long-term benefits of regular breast screening...
Breast Cancer Patients And Families Stand Up To FDA
6/29/2011
Breast cancer patients and their families will rally together on Tuesday, June 28, at 7:00 am outside of the Federal Drug Administration (FDA). At issue will be the FDA's final hearing to remove the anti-cancer drug Avastin from the approved medication list for treatment of late stage breast cancer, despite the FDA approving it in 2008 for use to treat breast cancer...
Recent Study Shows Leukothera™ Combined With Other Agents Has Enhanced Anti-Leukemia Effects
6/29/2011
Recent findings published in the scientific journal Leukemia Research, showed that when combined with standard anti-leukemia agents, the biological activity of LeukotheraTM, a drug candidate under development by Actinobac Biomed, Inc., showed synergistic anti-leukemia effects...